Stifel Financial Corp Mimedx Group, Inc. Transaction History

Stifel Financial Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$5.7 - $9.14 $5,700 - $9,140	-1,000 Reduced 6.45%	14,500 $127,000
Q4 2022 Feb 13, 2023	SELL	$2.63 - $3.45 $2 - $3	-1 Reduced 0.01%	15,500 $43,000
Q3 2022 Nov 14, 2022	BUY	$2.71 - $4.22 $5,149 - $8,017	1,900 Added 13.97%	15,501 $44,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $5.0 $43,115 - $68,005	13,601 New	13,601 $47,000
Q1 2022 May 13, 2022	SELL	$4.27 - $6.27 $85,532 - $125,594	-20,031 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.7 - $8.48 $1,960 - $2,917	-344 Reduced 1.69%	20,031 $121,000
Q3 2021 Nov 15, 2021	SELL	$5.52 - $15.83 $32,308 - $92,652	-5,853 Reduced 22.32%	20,375 $123,000
Q1 2021 May 14, 2021	BUY	$8.48 - $11.28 $58,130 - $77,324	6,855 Added 35.38%	26,228 $270,000
Q4 2020 Feb 12, 2021	BUY	$5.32 - $10.17 $103,064 - $197,023	19,373 New	19,373 $176,000
Q1 2018 May 11, 2018	SELL	$6.69 - $17.96 $71,770 - $192,674	-10,728 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$10.87 - $13.9 $116,613 - $149,119	10,728	10,728 $135,000

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.